Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
OBJECTIVES:
I. Determine the pattern of immunologic reconstitution in patients with T-cell compromise due to DiGeorge syndrome or velocardiofacial syndrome.
II. Determine any correlation between immunologic function in these patients and chromosome 22 deletion breakpoints.
III. Determine presence of sustained immunologic compromise in older patients.
| Condition |
|---|
|
DiGeorge Syndrome Shprintzen Syndrome Chromosome Abnormalities Abnormalities, Multiple Conotruncal Cardiac Defects |
| Study Type: | Observational |
| Study Design: | Observational Model: Natural History |
| Official Title: | Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome |
| Estimated Enrollment: | 11 |
| Study Start Date: | January 1995 |
PROTOCOL OUTLINE:
Blood samples are collected at diagnosis of chromosome 22q11 deletion and assessed for lymphocyte proliferation in response to mitogens phytohemagglutinin, pokeweed mitogen, and concanavalin A (mitogen stimulation analyses). These analyses are repeated at 4 months along with a quantitative analysis of immunoglobulin.
At 8 months, patients are tested for their lymphocytes' ability to respond to antigens (candida, tetanus, and diphtheria). At 1 year, patients have lymphocyte subset, IgG, IgA, and IgM analyses performed. Quantitative evaluations of antibody titers to diphtheria, tetanus, Haemophilus influenza, and hepatitis B are also performed.
Over 1 year of age, all studies are performed if the patient is seen for a single visit.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- Conotruncal cardiac lesion to be repaired by surgery AND Chromosome 22q11 deletion by FISH
Contacts and Locations| United States, Pennsylvania | |
| Children's Hospital of Philadelphia | Recruiting |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Contact: Kathleen E. Sullivan 215-590-1697 | |
| Study Chair: | Kathleen E. Sullivan | Children's Hospital of Philadelphia |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00005102 History of Changes |
| Other Study ID Numbers: | NCRR-M01RR00240-1571, CHP-IRB-95-903, CHP-GCRC-1571 |
| Study First Received: | April 6, 2000 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Center for Research Resources (NCRR):
|
DiGeorge syndrome Shprintzen syndrome cardiovascular and respiratory diseases |
conotruncal cardiac defects genetic diseases and dysmorphic syndromes rare disease |
Additional relevant MeSH terms:
|
Congenital Abnormalities Abnormalities, Multiple Craniofacial Abnormalities Musculoskeletal Abnormalities Cardiovascular Abnormalities Lymphatic Abnormalities Chromosome Aberrations Chromosome Disorders DiGeorge Syndrome Heart Defects, Congenital |
Pathologic Processes Genetic Diseases, Inborn 22q11 Deletion Syndrome Musculoskeletal Diseases Cardiovascular Diseases Heart Diseases Lymphatic Diseases Hypoparathyroidism Parathyroid Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013